Hazem Hassan

Dr. Hazem Hassan is a prominent researcher at the University of Capital (formerly Helwan University) who has recently achieved a significant scientific breakthrough in the treatment of congenital deafness. His innovative research focuses on gene therapy, specifically the development of a novel genetic treatment known as DB-OTO, aimed at addressing hearing loss caused by mutations in the otoferlin gene. This research holds great promise for restoring hearing in children affected by this condition, offering hope where traditional treatments have been ineffective.